What does the evidence say about Hyaluronic Acid Joint Pain Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Hyaluronic Acid Joint Pain Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Conclusion Ultrasound-guided hyaluronic acid injection and supervised rehabilitation produced comparable and clinically meaningful improvements in pain, function, and shoulder mobility in frozen-phase adhesive capsulitis. [Chang CY (2026); evidence level 2] - Objective To compare the efficacy and safety of ultrasound-guided intra-articular hyaluronic acid injection versus supervised rehabilitation in patients with frozen-phase adhesive capsulitis. [Chang CY (2026); evidence level 2] - Design Single-center, parallel-group, randomized controlled trial with 26-week follow-up. [Chang CY (2026); evidence level 2] - 1 2 3 4 5 Osteoarthritis (OA) is a degenerative disease characterized by the progressive degeneration of articular cartilage, the development of osteophytes, alterations in subchondral bone and synovial hyperplasia, clinically responsible for increasing disability and reduced quality of life []. [Riglet Louis (2026); evidence level 2] - In vitro studies also suggest improved stimulation of chondrogenesis, and a reduction in both inflammation and chondrocyte catabolism [,]. [Riglet Louis (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.